Author Interviews, Genetic Research, Nature, Scripps / 21.06.2017
Rapid Improvements Coming to Gene Editing Techniques
MedicalResearch.com Interview with:
[caption id="attachment_35494" align="alignleft" width="146"]
Dr. Farzan[/caption]
Michael Farzan PhD
Co-chair and Professor
Department of Immunology and Microbiology
Florida Campus
The Scripps Research Institute
Jupiter, Florida
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: CRISPR is system for immune protection of bacteria. It has now been widely adopted for use in editing mammalian cells. The most commonly used CRISPR effector protein is Cas9. Cas9 binds a guide RNA to recognize a DNA target, for example an incoming virus infecting a bacterium, or a gene in a human chromosome. In bacteria, Cas9 requires a second protein to clear the guide RNA from a longer "CRISPR array", basically a string of guide RNAs.
We have been studying a CRISPR effector protein related to Cas9 called Cpf1. In bacteria it was know that, unlike Cas9, Cpf1 could cleave a CRISPR array by itself, without assistance from a second protein. We knew that if it could do the same thing in human cells, it would help to simplify a number of gene-editing applications. We were able to show that Cas9 could indeed excise multiple guide RNAs from a single message RNA in human cells. We further showed that this approach was more efficient than the previous ways that guide RNAs were generated for gene editing, even more so when multiple guide RNAs were needed.
Dr. Farzan[/caption]
Michael Farzan PhD
Co-chair and Professor
Department of Immunology and Microbiology
Florida Campus
The Scripps Research Institute
Jupiter, Florida
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: CRISPR is system for immune protection of bacteria. It has now been widely adopted for use in editing mammalian cells. The most commonly used CRISPR effector protein is Cas9. Cas9 binds a guide RNA to recognize a DNA target, for example an incoming virus infecting a bacterium, or a gene in a human chromosome. In bacteria, Cas9 requires a second protein to clear the guide RNA from a longer "CRISPR array", basically a string of guide RNAs.
We have been studying a CRISPR effector protein related to Cas9 called Cpf1. In bacteria it was know that, unlike Cas9, Cpf1 could cleave a CRISPR array by itself, without assistance from a second protein. We knew that if it could do the same thing in human cells, it would help to simplify a number of gene-editing applications. We were able to show that Cas9 could indeed excise multiple guide RNAs from a single message RNA in human cells. We further showed that this approach was more efficient than the previous ways that guide RNAs were generated for gene editing, even more so when multiple guide RNAs were needed.













